Covered recipient · General Payments record
JOHN F ROBINSON
Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology
General Payments · PY2018–2020
$6,144.19
- Reported across 165 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2020 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $163.80 | 9 |
By paying entity
PY2020 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| NOVARTIS PHARMACEUTICALS CORPORATION | $66.40 | 3 |
| GENZYME CORPORATION | $33.30 | 2 |
| Rigel Pharmaceuticals, Inc. | $18.56 | 1 |
| GlaxoSmithKline, LLC. | $16.88 | 1 |
| Coherus Biosciences Inc. | $14.36 | 1 |
| Kite Pharma, Inc. | $14.30 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2020 (9)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Coherus Biosciences Inc. | $14.36 | 01/22/2020 | Food and Beverage | Undisputed | 01/23/2026 | 750863535 | CMS |
| GENZYME CORPORATION | $16.83 | 02/05/2020 | Food and Beverage | Undisputed | 01/23/2026 | 744167813 | CMS |
| GENZYME CORPORATION | $16.47 | 02/12/2020 | Food and Beverage | Undisputed | 01/23/2026 | 744167815 | CMS |
| GlaxoSmithKline, LLC. | $16.88 | 01/21/2020 | Food and Beverage | Undisputed | 01/23/2026 | 738496195 | CMS |
| Kite Pharma, Inc. | $14.30 | 01/30/2020 | Food and Beverage | Undisputed | 01/23/2026 | 731503241 | CMS |
| Novartis Pharmaceuticals Corporation | $19.96 | 01/09/2020 | Food and Beverage | Undisputed | 01/23/2026 | 726103397 | CMS |
| Novartis Pharmaceuticals Corporation | $23.42 | 02/10/2020 | Food and Beverage | Undisputed | 01/23/2026 | 726103403 | CMS |
| Novartis Pharmaceuticals Corporation | $23.02 | 02/13/2020 | Food and Beverage | Undisputed | 01/23/2026 | 726103401 | CMS |
| Rigel Pharmaceuticals, Inc. | $18.56 | 01/16/2020 | Food and Beverage | Undisputed | 01/23/2026 | 752090845 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020
- Generated from
- OP_DTL_GNRL_PGYR2020_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.